臨床試驗

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

NCT：NCT06929702 · RECRUITING

NCT IDNCT06929702

狀態RECRUITING

開始日期2025-07-09

完成時間2027-10-01

SponsorUniversity Hospital, Ghent (OTHER)

First posted2025-04-16

Last updated2026-09-17

簡要摘要

The overall objective of this study is to investigate the impact of early model-informed precision dosing (MIPD) on target attainment of three beta-lactam antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem) in critically ill children. This evaluation includes a comparison with the more standard approach on clinical and patient-oriented measures.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。